Cargando…

Editorial: Application of nanotechnology in diagnosis and/or therapy of non-small cell lung cancer

Detalles Bibliográficos
Autores principales:	Shen, Qinglin, Peng, Ling, Zhang, Yi, Wang, Ruoxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314132/ https://www.ncbi.nlm.nih.gov/pubmed/37397385 http://dx.doi.org/10.3389/fonc.2023.1234727

Ejemplares similares

The Application of Nanotechnology and Nanomaterials in Cancer Diagnosis and Treatment: A Review
por: Kher, Chinmay, et al.
Publicado: (2022)

Advanced diagnostic and therapeutic strategies in nanotechnology for lung cancer
por: Duan, Yujuan, et al.
Publicado: (2022)

Editorial: Imaging in non-small cell lung cancer
por: Liu, Yiyan
Publicado: (2023)

Advances in Photodynamic Therapy Based on Nanotechnology and Its Application in Skin Cancer
por: Zhang, Ping, et al.
Publicado: (2022)

NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance
por: Liu, Fangfang, et al.
Publicado: (2022)

Editorial: Prognostic factors in non-small cell lung cancer
por: Rahouma, Mohamed, et al.
Publicado: (2023)

Editorial: Factors that impact the survival of non-small cell lung cancer
por: Hegi-Johnson, Fiona, et al.
Publicado: (2023)

Editorial: Treatment for Non-Small Cell Lung Cancer in Distinct Patient Populations
por: Uchino, Junji, et al.
Publicado: (2022)

Engineering Macrophages via Nanotechnology and Genetic Manipulation for Cancer Therapy
por: Ding, Xiaoling, et al.
Publicado: (2022)

Maintenance Therapies for Non-Small Cell Lung Cancer
por: Blais, Normand, et al.
Publicado: (2014)

Targeted therapy of RET fusion-positive non-small cell lung cancer
por: Shen, Zixiong, et al.
Publicado: (2022)

Biomedical Applications of Non-Small Cell Lung Cancer Spheroids
por: Rozenberg, Julian M., et al.
Publicado: (2021)

Nanotechnology in Lung Cancer Therapeutics: A Narrative Review
por: Koutu, Vaibhav, et al.
Publicado: (2023)

An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer
por: Qi, Yuwen, et al.
Publicado: (2023)

Editorial: Magnetic resonance imaging applications for the diagnosis of prostate cancer
por: Preisser, Felix, et al.
Publicado: (2023)

Application of Nanotechnology in Cancer Diagnosis and Therapy - A Mini-Review
por: Jin, Cancan, et al.
Publicado: (2020)

Editorial: Long non-coding RNAs in lung cancer
por: Malapelle, Umberto, et al.
Publicado: (2022)

Editorial: Local ablative therapies for the management of lung cancer
por: Wei, Zhigang, et al.
Publicado: (2023)

Case Report: Transformation From Non-Small Cell Lung Cancer to Small Cell Lung Cancer During Anti-PD-1 Therapy: A Report of Two Cases
por: Shen, Qian, et al.
Publicado: (2021)

Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer
por: Puri, Sonam, et al.
Publicado: (2020)

Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
por: Melosky, Barbara
Publicado: (2017)

Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis
por: Zhang, Wei, et al.
Publicado: (2022)

Local therapy treatment conditions for oligometastatic non-small cell lung cancer
por: Zhang, Suli, et al.
Publicado: (2022)

DNA Nanotechnology for Cancer Diagnosis and Therapy
por: Chen, Tianshu, et al.
Publicado: (2018)

Nanotechnology in diagnosis and therapy of gastrointestinal cancer
por: Liang, Meng, et al.
Publicado: (2022)

Editorial: The effect of anti-cancer drug therapies in the treatment of lung cancer
por: Pisapia, Pasquale, et al.
Publicado: (2022)

Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
por: Yang, Jialiang, et al.
Publicado: (2021)

Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis
por: Zhang, Wei, et al.
Publicado: (2022)

Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer
por: Shen, Mo, et al.
Publicado: (2022)

The role of targeted therapy and immune therapy in the management of non-small cell lung cancer brain metastases
por: Billena, Cole, et al.
Publicado: (2023)

Melanoma and Nanotechnology-Based Treatment
por: Zeng, Hong, et al.
Publicado: (2022)

The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer
por: Saarenheimo, Jatta, et al.
Publicado: (2019)

Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer
por: Fang, Xiaoxu, et al.
Publicado: (2022)

Application of nanotechnology in the diagnosis and treatment of bladder cancer
por: Xu, Yadong, et al.
Publicado: (2021)

The Molecular Role of IL-35 in Non-Small Cell Lung Cancer
por: Hao, Yuqiu, et al.
Publicado: (2022)

Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy
por: Kumar, Sameera S., et al.
Publicado: (2017)

Editorial: Multidisciplinary Approach to the Diagnosis and Therapy of Skin Neoplasms
por: Ronchi, Andrea, et al.
Publicado: (2022)

Use of Pralsetinib as Neoadjuvant Therapy for Non-Small Cell Lung Cancer Patient With RET Rearrangement
por: Zhou, Ning, et al.
Publicado: (2022)

Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy
por: Xiang, Zhangqiang, et al.
Publicado: (2022)

Microwave ablation plus camrelizumab monotherapy or combination therapy in non-small cell lung cancer
por: Huang, Yahan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p2c6shka5q1t431j2bb6kh81ra